Oral Mycobiome Analysis of HIV-Infected Patients: Identification of Pichia as an Antagonist of Opportunistic Fungi

PLoS Pathogens

Volumn 10, Issue 3, 2014, Pages

  Mukherjee, Pranab K ^a   Chandra, Jyotsna ^a   Retuerto, Mauricio ^a   Sikaroodi, Masoumeh ^b   Brown, Robert E ^b   Jurevic, Richard ^b   Salata, Robert A ^c   Lederman, Michael M ^d   Gillevet, Patrick M ^b   Ghannoum, Mahmoud A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOSIS; ARTICLE; ASPERGILLUS; BIOFILM; CANDIDA; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FUNGAL COLONIZATION; FUNGUS GROWTH; FUSARIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOUSE; MOUTH DISEASE; MOUTH FLORA; NONHUMAN; OPPORTUNISTIC INFECTION; PICHIA; PYROSEQUENCING; THRUSH; YOUNG ADULT;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; FEMALE; FUNGAL PROTEINS; HIV INFECTIONS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOUTH; PICHIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84897392010     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003996     Document Type: Article

References (82)

1. Jenkinson HF, Lamont RJ, (2005) Oral microbial communities in sickness and in health. Trends Microbiol 13: 589-595.
2. Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH, et al. (2002) Prevalence and classification of HIV-associated oral lesions. Oral Dis 8: 98-109.
3. Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC, et al. (2005) Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent Oral Epidemiol 33: 35-44.
4. Koletar SL, Smurzynski M, Wu K, Collier AC, Bosch RJ, et al. AIDS-defining illnesses occurring in treatment-experienced HIV-1-infected persons followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) study [Abstract 1017]. In Proceedings of the 15th Conference on Retroviruses & Opportunistic Infections; February 3-6, 2008; Boston, MA. Available: http://retroconference.org/. Accessed 2/3/13.
5. Thompson GR 3rd, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, et al. (2010) Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 488-495.
6. Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, et al. (2012) The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy. AIDS Res Treat 2012: 262471.
7. Kinross JM, Darzi AW, Nicholson JK, (2011) Gut microbiome-host interactions in health and disease. Genome Med 3: 14.
8. Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, et al. (2010) A catalog of reference genomes from the human microbiome. Science 328: 994-999.
9. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, et al. (2009) Topographical and temporal diversity of the human skin microbiome. Science 324: 1190-1192.
10. Huse SM, Ye Y, Zhou Y, Fodor AA, (2012) A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters. PLoS ONE 7: e34242.
11. Clemente JC, Ursell LK, Parfrey LW, Knight R, (2012) The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell 148: 1258-1270.
12. Aas JA, Barbuto SM, Alpagot T, Olsen I, Dewhirst FE, et al. (2007) Subgingival plaque microbiota in HIV positive patients. Journal of Clinical Periodontology 34: 189-195.
13. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, et al. (2012) Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis. Science 336: 1314-1317.
14. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, et al. (2010) Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals. PLoS Pathogens 6: e1000713.
15. Peleg AY, Hogan DA, Mylonakis E, (2010) Medically important bacterial-fungal interactions. Nat Rev Microbiol 8: 340-349.
16. Landlinger C, Baskova L, Preuner S, Willinger B, Buchta V, et al. (2008) Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur J Clin Microbiol Infect Dis 28 (6) (): 613-22.
17. Borman AM, Linton CJ, Miles SJ, Johnson EM, (2008) Molecular identification of pathogenic fungi. Journal of Antimicrobial Chemotherapy 61: i7-12.
18. Gillevet P, Sikaroodi M, Keshavarzian A, Mutlu EA, (2010) Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7: 1065-1075.
19. Chakravorty S, Helb D, Burday M, Connell N, Alland D, (2007) A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. Journal of Microbiological Methods 69: 330-339.
20. Spear GT, Sikaroodi M, Zariffard MR, Landay AL, French AL, et al. (2008) Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis 198: 1131-1140.
21. Gillevet PM, inventor; BioSpherex LLC, assignee (2013 December 10) Multitag Sequencing and Ecogenomic Analysis. United States Patent 8,603,749.
22. Romanelli AM, Sutton DA, Thompson EH, Rinaldi MG, Wickes BL, (2010) Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note. J Clin Microbiol 48: 741-752.
23. Cormack BP, Bertram G, Egerton M, Gow NA, Falkow S, et al. (1997) Yeast-enhanced green fluorescent protein (yEGFP) a reporter of gene expression in Candida albicans. Microbiology 143: 303-311.
24. Swindell K, Lattif AA, Chandra J, Mukherjee PK, Ghannoum MA, (2009) Parenteral Lipid Emulsion Induces Germination of Candida albicans and Increases Biofilm Formation on Medical Catheter Surfaces. J Infect Dis 200: 473-480.
25. Kuhn DM, Mukherjee PK, Clarke TA, Pujol C, Chandra J, et al. (2004) Candida parapsilosis characterization in an outbreak setting. Emerging Infectious Diseases 10: 1074-1081.
26. Chandra J, Mukherjee PK, Ghannoum MA, (2008) In vitro growth and analysis of Candida biofilms. Nature Protocols 3: 1909-1924.
27. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, et al. (2001) Biofilm formation by the fungal pathogen Candida albicans- development, architecture and drug resistance. Journal of Bacteriology 183: 5385-5394.
28. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, et al. (2001) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. Journal of Dental Research 80: 903-908.
29. Pienaar ED, Young T, Holmes H, (2010) Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database of Systematic Reviews 11: CD003940.
30. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, et al. (2009) An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5: 487-497.
31. Tang N, Liu L, Kang K, Mukherjee PK, Takahara M, et al. (2004) Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase. Infection and Immunity 72: 2513-2520.
32. Ghannoum MA, Mukherjee PK, Jurevic RJ, Retuerto M, Brown RE, et al. (2011) Metabolomics Reveals Differential Levels of Oral Metabolites in HIV-Infected Patients: Toward Novel Diagnostic Targets. Omics 17: 5-15.
33. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335-336.
34. R Core Team (2013) R: A language and environment for statistical computing. Available http://www.R-project.org. Accessed 2 February 2013.
35. Revelle W (2013) psych: procedures for personality and psychological research. Available http://CRAN.R-project.org/package=psych Version = 1.3.10. Accessed 20 December 2013.
36. Nokta M, (2008) Oral manifestations associated with HIV infection. Curr HIV/AIDS Rep 5: 5-12.
37. Schisler D, Kurtzman C, Bothast R, Slininger P, (1995) Evaluation of yeasts for biological control of Fusarium dry rot of potatoes. American Potato Journal 72: 339-353.
38. Starmer WT, Ganter PF, Phaff HJ, (1986) Quantum and continuous evolution of DNA base composition in the yeast genus Pichia. Evolution 40: 1263-1274.
39. Golubev W (2006) Antagonistic interactions among yeasts. Biodiversity and Ecophysiology of Yeasts: Springer. pp. 197-219.
40. Antunes J, Aguiar C, (2012) Search for killer phenotypes with potential for biological control. Annals of microbiology 62: 427-433.
41. Druvefors UA, Schnurer J, (2005) Mold-inhibitory activity of different yeast species during airtight storage of wheat grain. FEMS Yeast Res 5: 373-378.
42. Jung PP, Friedrich A, Souciet JL, Louis V, Potier S, et al. (2010) Complete mitochondrial genome sequence of the yeast Pichia farinosa and comparative analysis of closely related species. Curr Genet 56: 507-515.
43. Walker GM, (2010) Pichia anomala: cell physiology and biotechnology relative to other yeasts. Antonie Van Leeuwenhoek 99 (1) (): 25-34.
44. Elad Y, (2003) Biocontrol of foliar pathogens: mechanisms and application. Commun Agric Appl Biol Sci 68: 17-24.
45. Cao S, Yuan Y, Hu Z, Zheng Y, (2010) Combination of Pichia membranifaciens and ammonium molybdate for controlling blue mould caused by Penicillium expansum in peach fruit. Int J Food Microbiol 141: 173-176.
46. Santos A, San Mauro M, Bravo E, Marquina D, (2009) PMKT2, a new killer toxin from Pichia membranifaciens, and its promising biotechnological properties for control of the spoilage yeast Brettanomyces bruxellensis. Microbiology 155: 624-634.
47. Olstorpe M, Passoth V, (2010) Pichia anomala in grain biopreservation. Antonie Van Leeuwenhoek 99 (1) (): 57-62.
48. Kagan BL, (1983) Mode of action of yeast killer toxins: channel formation in lipid bilayer membranes. Nature 302: 709-711.
49. İzgü F, Alti{dotless}nbay D, Acun T, (2006) Killer toxin of Pichia anomala NCYC 432; purification, characterization and its exo-β-1,3-glucanase activity. Enzyme and Microbial Technology 39: 669-676.
50. Cao S, Zheng Y, Tang S, Wang K, (2008) Improved control of anthracnose rot in loquat fruit by a combination treatment of Pichia membranifaciens with CaCl(2). Int J Food Microbiol 126: 216-220.
51. Druvefors UA, Passoth V, Schnurer J, (2005) Nutrient effects on biocontrol of Penicillium roqueforti by Pichia anomala J121 during airtight storage of wheat. Appl Environ Microbiol 71: 1865-1869.
52. Xu XB, Tian SP, (2008) Reducing oxidative stress in sweet cherry fruit by Pichia membranaefaciens: a possible mode of action against Penicillium expansum. J Appl Microbiol 105: 1170-1177.
53. Zhao J, Mou Y, Shan T, Li Y, Zhou L, et al. (2010) Antimicrobial metabolites from the endophytic fungus Pichia guilliermondii isolated from Paris polyphylla var. yunnanensis. Molecules 15: 7961-7970.
54. Jijakli MH, Lepoivre P, (1998) Characterization of an Exo-beta-1,3-Glucanase Produced by Pichia anomala Strain K, Antagonist of Botrytis cinerea on Apples. Phytopathology 88: 335-343.
55. Droby S, Hofstein R, Wilson CL, Wisniewski M, Fridlender B, et al. (1993) Pilot Testing of Pichia guilliermondii: A Biocontrol Agent of Postharvest Diseases of Citrus Fruit. Biological Control 3: 47-52.
56. Droby S, Wisniewski ME, Cohen L, Weiss B, Touitou D, et al. (1997) Influence of CaCl(2) on Penicillium digitatum, Grapefruit Peel Tissue, and Biocontrol Activity of Pichia guilliermondii. Phytopathology 87: 310-315.
57. Giobbe S, Marceddu S, Scherm B, Zara G, Mazzarello VL, et al. (2007) The strange case of a biofilm-forming strain of Pichia fermentans, which controls Monilinia brown rot on apple but is pathogenic on peach fruit. FEMS Yeast Res 7: 1389-1398.
58. Kumamoto CA, Vinces MD, (2005) Alternative Candida albicans lifestyles: Growth on Surfaces. Annual Review of Microbiology 59: 113-133.
59. Chandra J, Mukherjee PK, Ghannoum MA, (2011) Candida Biofilms Associated with CVC and Medical Devices. Mycoses 55: 46-57.
60. Chandra J, Mukherjee PK, Ghannoum MA, (2010) Fungal Biofilms in the Clinical Lab Setting. Current Reports in Fungal Infection 4: 137-144.
61. Conlan S, Kong HH, Segre JA, (2012) Species-level analysis of DNA sequence data from the NIH Human Microbiome Project. PLoS One 7: e47075.
62. Li K, Bihan M, Yooseph S, Methe BA, (2012) Analyses of the microbial diversity across the human microbiome. PLoS One 7: e32118.
63. Zarco MF, Vess TJ, Ginsburg GS, (2012) The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 18: 109-120.
64. Zaura E, Keijser BJ, Huse SM, Crielaard W, (2009) Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 9: 259.
65. Hogan DA, Kolter R, (2002) Pseudomonas- Candida interactions: an ecological role for virulence factors. Science 296: 2229-2232.
66. Azoulay E, Timsit J-F, Tafflet M, de Lassence A, Darmon M, et al. (2006) Candida Colonization of the Respiratory Tract and Subsequent Pseudomonas Ventilator-Associated Pneumonia. Chest 129: 110-117.
67. Nseir S, Jozefowicz E, Cavestri B, Sendid B, Di Pompeo C, et al. (2007) Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med 33: 137-142.
68. Dyess DL, Garrison RN, Fry DE, (1985) Candida sepsis. Implications of polymicrobial blood-borne infection. ArchSurg 120: 345-348.
69. Navazesh M, Mulligan R, Pogoda J, Greenspan D, Alves M, et al. (2005) The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 701-708.
70. Workman SN, Been FE, Crawford SR, Lavoie MC, (2008) Bacteriocin-like inhibitory substances from Campylobacter spp. Antonie Van Leeuwenhoek 93: 435-436.
71. Dupont PF, (1995) Candida albicans, the opportunist. A cellular and molecular perspective. JAmPodiatrMedAssoc 85: 104-115.
72. Martin MV, Craig GT, Lamb DJ, (1984) An investigation of the role of true hypha production in the pathogenesis of experimental oral candidosis. Sabouraudia 22: 471-476.
73. Cannon RD, Holmes AR, Mason AB, Monk BC, (1995) Oral Candida: clearance, colonization, or candidiasis? JDentRes 74: 1152-1161.
74. Samaranayake YH, Wu PC, Samaranayake LP, So M, Yuen KY, (1994) Adhesion and colonisation of Candida krusei on host surfaces. JMedMicrobiol 41: 250-258.
75. De Bernardis F, Boccanera M, Rainaldi L, Guerra CE, Quinti I, et al. (1992) The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. EurJEpidemiol 8: 362-367.
76. Sardi JC, Duque C, Hofling JF, Goncalves RB, (2012) Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol 50: 467-475.
77. Ghannoum MA, Abu-Elteen KH, (1990) Pathogenicity determinants of Candida. Mycoses 33: 265-282.
78. Ghannoum MA, (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clinical Microbiology Reviews 13: 122-143.
79. Richardson MD, Smith H, (1981) Production of germ tubes by virulent and attenuated strains of Candida albicans. J Infect Dis 144: 565-569.
80. Restuccia C, Giusino F, Licciardello F, Randazzo C, Caggia C, et al. (2006) Biological control of peach fungal pathogens by commercial products and indigenous yeasts. J Food Prot 69: 2465-2470.
81. Santos A, Marquina D, (2004) Ion channel activity by Pichia membranifaciens killer toxin. Yeast 21: 151-162.
82. Fredlund E, Broberg A, Boysen ME, Kenne L, Schnurer J, (2004) Metabolite profiles of the biocontrol yeast Pichia anomala J121 grown under oxygen limitation. Appl Microbiol Biotechnol 64: 403-409.